(SITM) Sitime - Overview
Sector: TechnologyIndustry: Semiconductors | Exchange NASDAQ (USA) | Currency USD | Market Cap: 9.319m | Total Return 87.9% in 12m
Stock: Timing Systems, Oscillators, Clock ICs, Resonators
Total Rating 67
Risk 77
Buy Signal -0.76
| Risk 5d forecast | |
|---|---|
| Volatility | 79.2% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 49.46 |
| Character TTM | |
|---|---|
| Beta | 2.841 |
| Beta Downside | 3.047 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.26% |
| CAGR/Max DD | 0.62 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: SITM Sitime March 04, 2026
SiTime Corporation designs and sells silicon timing systems. These systems include oscillators, clock integrated circuits, resonators, and synchronization software.
The companys products are used across diverse markets such as AI, data centers, automotive, and aerospace. Timing solutions are critical components in electronic systems, providing the precise clock signals needed for data processing and communication.
SiTime operates globally, with significant presence in Hong Kong, Taiwan, and the United States. For a deeper dive into SiTimes financial health, consider exploring its profile on ValueRay.
Headlines to watch out for
- AI systems and data center expansion drive oscillator demand
- Automotive and industrial sector growth boosts timing chip sales
- Communications infrastructure upgrades increase SiTime product adoption
- Global semiconductor supply chain disruptions impact production costs
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -42.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 4.18 > 1.0 |
| NWC/Revenue: 264.9% < 20% (prev 214.9%; Δ 49.98% < -1%) |
| CFO/TA 0.07 > 3% & CFO 87.2m > Net Income -42.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 11.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.1m) vs 12m ago 15.35% < -2% |
| Gross Margin: 53.57% > 18% (prev 0.52%; Δ 5.31k% > 0.5%) |
| Asset Turnover: 29.97% > 50% (prev 22.90%; Δ 7.07% > 0%) |
| Interest Coverage Ratio: -3.84 > 6 (EBITDA TTM -18.9m / Interest Expense TTM -14.9m) |
Altman Z'' 1.76
| A: 0.67 (Total Current Assets 949.3m - Total Current Liabilities 84.0m) / Total Assets 1.29b |
| B: -0.17 (Retained Earnings -224.9m / Total Assets 1.29b) |
| C: -0.05 (EBIT TTM -57.2m / Avg Total Assets 1.09b) |
| D: -1.62 (Book Value of Equity -224.9m / Total Liabilities 138.5m) |
| Altman-Z'' Score: 1.76 = BBB |
Beneish M -3.16
| DSRI: 0.73 (Receivables 45.0m/38.2m, Revenue 326.7m/202.7m) |
| GMI: 0.96 (GM 53.57% / 51.55%) |
| AQI: 0.64 (AQ_t 0.18 / AQ_t-1 0.28) |
| SGI: 1.61 (Revenue 326.7m / 202.7m) |
| TATA: -0.10 (NI -42.9m - CFO 87.2m) / TA 1.29b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of SITM shares?
As of March 27, 2026, the stock is trading at USD 334.67 with a total of 281,632 shares traded.
Over the past week, the price has changed by -6.10%, over one month by -15.88%, over three months by -11.25% and over the past year by +87.90%.
Over the past week, the price has changed by -6.10%, over one month by -15.88%, over three months by -11.25% and over the past year by +87.90%.
Is SITM a buy, sell or hold?
Sitime has received a consensus analysts rating of 3.86.
Therefore, it is recommended to buy SITM.
- StrongBuy: 2
- Buy: 3
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the SITM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 452.2 | 35.1% |
| Analysts Target Price | 452.2 | 35.1% |
SITM Fundamental Data Overview March 26, 2026
P/E Forward = 68.0272
P/S = 28.5293
P/B = 7.8744
P/EG = 3.381
Revenue TTM = 326.7m USD
EBIT TTM = -57.2m USD
EBITDA TTM = -18.9m USD
Long Term Debt = 3.61m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.48m USD (from shortTermDebt, last quarter)
Debt = 4.74m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -12.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.52b USD (9.32b + Debt 4.74m - CCE 808.4m)
Interest Coverage Ratio = -3.84 (Ebit TTM -57.2m / Interest Expense TTM -14.9m)
EV/FCF = 244.3x (Enterprise Value 8.52b / FCF TTM 34.9m)
FCF Yield = 0.41% (FCF TTM 34.9m / Enterprise Value 8.52b)
FCF Margin = 10.67% (FCF TTM 34.9m / Revenue TTM 326.7m)
Net Margin = -13.13% (Net Income TTM -42.9m / Revenue TTM 326.7m)
Gross Margin = 53.57% ((Revenue TTM 326.7m - Cost of Revenue TTM 151.7m) / Revenue TTM)
Gross Margin QoQ = 56.39% (prev 53.51%)
Tobins Q-Ratio = 6.58 (Enterprise Value 8.52b / Total Assets 1.29b)
Interest Expense / Debt = 120.8% (Interest Expense 5.73m / Debt 4.74m)
Taxrate = 4.04% (386k / 9.55m)
NOPAT = -54.9m (EBIT -57.2m * (1 - 4.04%)) [loss with tax shield]
Current Ratio = 11.30 (Total Current Assets 949.3m / Total Current Liabilities 84.0m)
Debt / Equity = 0.00 (Debt 4.74m / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 0.64 (negative EBITDA) (Net Debt -12.0m / EBITDA -18.9m)
Debt / FCF = -0.34 (Net Debt -12.0m / FCF TTM 34.9m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.94% (Net Income -42.9m / Total Assets 1.29b)
RoE = -4.23% (Net Income TTM -42.9m / Total Stockholder Equity 1.01b)
RoCE = -5.62% (EBIT -57.2m / Capital Employed (Equity 1.01b + L.T.Debt 3.61m))
RoIC = -5.42% (negative operating profit) (NOPAT -54.9m / Invested Capital 1.01b)
WACC = 15.96% (E(9.32b)/V(9.32b) * Re(15.97%) + (debt cost/tax rate unavailable))
Discount Rate = 15.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.56%
[DCF] Terminal Value 43.56% ; FCFF base≈34.9m ; Y1≈22.9m ; Y5≈10.5m
[DCF] Fair Price = 3.92 (EV 91.1m - Net Debt -12.0m = Equity 103.1m / Shares 26.3m; r=15.96% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -20.66 | EPS CAGR: 13.87% | SUE: 4.0 | # QB: 8
Revenue Correlation: 26.58 | Revenue CAGR: 13.59% | SUE: 4.0 | # QB: 7
EPS next Quarter (2026-06-30): EPS=1.18 | Chg7d=+0.242 | Chg30d=+0.259 | Revisions Net=+7 | Analysts=9
EPS current Year (2026-12-31): EPS=5.19 | Chg7d=+0.879 | Chg30d=+0.929 | Revisions Net=+8 | Growth EPS=+62.1% | Growth Revenue=+47.6%
EPS next Year (2027-12-31): EPS=6.60 | Chg7d=+0.407 | Chg30d=+0.422 | Revisions Net=+2 | Growth EPS=+27.2% | Growth Revenue=+27.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)
P/S = 28.5293
P/B = 7.8744
P/EG = 3.381
Revenue TTM = 326.7m USD
EBIT TTM = -57.2m USD
EBITDA TTM = -18.9m USD
Long Term Debt = 3.61m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.48m USD (from shortTermDebt, last quarter)
Debt = 4.74m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -12.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.52b USD (9.32b + Debt 4.74m - CCE 808.4m)
Interest Coverage Ratio = -3.84 (Ebit TTM -57.2m / Interest Expense TTM -14.9m)
EV/FCF = 244.3x (Enterprise Value 8.52b / FCF TTM 34.9m)
FCF Yield = 0.41% (FCF TTM 34.9m / Enterprise Value 8.52b)
FCF Margin = 10.67% (FCF TTM 34.9m / Revenue TTM 326.7m)
Net Margin = -13.13% (Net Income TTM -42.9m / Revenue TTM 326.7m)
Gross Margin = 53.57% ((Revenue TTM 326.7m - Cost of Revenue TTM 151.7m) / Revenue TTM)
Gross Margin QoQ = 56.39% (prev 53.51%)
Tobins Q-Ratio = 6.58 (Enterprise Value 8.52b / Total Assets 1.29b)
Interest Expense / Debt = 120.8% (Interest Expense 5.73m / Debt 4.74m)
Taxrate = 4.04% (386k / 9.55m)
NOPAT = -54.9m (EBIT -57.2m * (1 - 4.04%)) [loss with tax shield]
Current Ratio = 11.30 (Total Current Assets 949.3m / Total Current Liabilities 84.0m)
Debt / Equity = 0.00 (Debt 4.74m / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 0.64 (negative EBITDA) (Net Debt -12.0m / EBITDA -18.9m)
Debt / FCF = -0.34 (Net Debt -12.0m / FCF TTM 34.9m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.94% (Net Income -42.9m / Total Assets 1.29b)
RoE = -4.23% (Net Income TTM -42.9m / Total Stockholder Equity 1.01b)
RoCE = -5.62% (EBIT -57.2m / Capital Employed (Equity 1.01b + L.T.Debt 3.61m))
RoIC = -5.42% (negative operating profit) (NOPAT -54.9m / Invested Capital 1.01b)
WACC = 15.96% (E(9.32b)/V(9.32b) * Re(15.97%) + (debt cost/tax rate unavailable))
Discount Rate = 15.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.56%
[DCF] Terminal Value 43.56% ; FCFF base≈34.9m ; Y1≈22.9m ; Y5≈10.5m
[DCF] Fair Price = 3.92 (EV 91.1m - Net Debt -12.0m = Equity 103.1m / Shares 26.3m; r=15.96% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -20.66 | EPS CAGR: 13.87% | SUE: 4.0 | # QB: 8
Revenue Correlation: 26.58 | Revenue CAGR: 13.59% | SUE: 4.0 | # QB: 7
EPS next Quarter (2026-06-30): EPS=1.18 | Chg7d=+0.242 | Chg30d=+0.259 | Revisions Net=+7 | Analysts=9
EPS current Year (2026-12-31): EPS=5.19 | Chg7d=+0.879 | Chg30d=+0.929 | Revisions Net=+8 | Growth EPS=+62.1% | Growth Revenue=+47.6%
EPS next Year (2027-12-31): EPS=6.60 | Chg7d=+0.407 | Chg30d=+0.422 | Revisions Net=+2 | Growth EPS=+27.2% | Growth Revenue=+27.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Next Quarter)